documents: FDA-2026-N-3500-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-N-3500-0001 FDA FDA-2026-N-3500 Notice of Approval of Product Under Priority Review Voucher; Material Threat Medical Countermeasure Priority Review Voucher; MRESVIA (Respiratory Syncytial Virus Vaccine) Notice Notice of Approval 2026-04-16T04:00:00Z 2026 4     2026-04-16T17:45:21Z 2026-07369 0 0 09000064b9286771

Links from other tables